Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 14, 2015; 21(10): 3072-3084
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.3072
Published online Mar 14, 2015. doi: 10.3748/wjg.v21.i10.3072
Trial | Type of IBS | Criteria | Age (yr) | Sex (Male/Female) | Probiotic | Probiotic dosage | Duration of treatment | Follow-up | Outcome | ||
Probiotic | Placebo | Probiotic | Placebo | ||||||||
Agrawal et al[51] | C-IBS | Rome III | 39.6 | 0/19 | 0/19 | Bifidobacteriumlactis DN-173010 | 1.25 × 1010 CFU | 4 wk | 1 wk | ↓ Abdominal distension and bloating | |
Hun[48] | D-IBS | Rome II | 48.36 | 9/41 | Bacillusc oagulans GBI-306086 | 8× 108 CFU | 8 wk | - | ↓ Bloating and abdominal pain | ||
Dolin[67] | D-IBS | Rome III | 52.3 | 44 | 7/19 | 6/23 | B. coagulans GBI-306086 | 2 × 109 CFU | 8wk | 2 wk | ↓ Number of daily bowel movements |
Guandalini et al[47] | Alltypes | Rome II | 4-18 | 31/28 | VSL#3 | 4.5 × 1011 bacteria | 6 wk | 6 wk after 2-wk wash-out | ↓ Percentage of symptoms, severity and frequency of abdominal pain and bloating | ||
↑ QoL | |||||||||||
Ligaarden et al[53] | All types | Rome II | 46.5 (18-75) | 5/11 | Lactobacillusplantarum MF1298 | 1 × 1010 CFU | 3 wk | - | Daily symptom scores not different between probiotic and placebo groups | ||
Francavilla et al[50] | ND | Rome II | 6.5 | 6.3 | 43/24 | 35/23 | L. rhamnosus GG | 3 × 109 CFU | 12wk | 8 wk | ↓ Frequency and severity of pain, and improved intestinal permeability |
Hong et al[49] | All types | Rome III | 33 | 33 | 12/25 | 10/26 | Lactobacillus sp. HY7801 | 4 × 109 CFU | 8 wk | - | ↑ Intestinal barrier function in females |
B. longum HY804 | ↓ Pain and flatulence defection | ||||||||||
L. brevis HY7401 | |||||||||||
Choi et al[54] | D-IBS, A-IBS | Rome II | 40.2 | 40.6 | 18/17 | 19/20 | Saccharomycesboulardii | 2 × 1011 CFU | 4 wk | - | ↑ QoL |
Michail et al[52] | D-IBS | Rome III | 21.8±17 | 5/10 | 3/6 | VSL#3 | 9 × 1011 bacteria | 8 wk | - | ↑ QoL | |
No change in gut microbiota | |||||||||||
↑ Specific GSRS-IBS scores |
- Citation: Didari T, Mozaffari S, Nikfar S, Abdollahi M. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol 2015; 21(10): 3072-3084
- URL: https://www.wjgnet.com/1007-9327/full/v21/i10/3072.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i10.3072